cefotiam has been researched along with Health Care Associated Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, K; Nagatake, T | 1 |
| Couvreur, ML; de Schepper, N; Hubrechts, JM; Kupperberg, E; Leger, J; Nulens, E; Nyssen, HJ; Vanhoof, R | 1 |
2 other study(ies) available for cefotiam and Health Care Associated Infection
| Article | Year |
|---|---|
[Drug therapy of intractable methicillin-resistant staphylococcal infections].
Topics: Cefotiam; Cross Infection; Drug Therapy, Combination; Glycopeptides; Humans; Imipenem; Methicillin Resistance; Minocycline; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 1990 |
Activity of cefotiam in combination with beta-lactam antibiotics on enterobacterial hospital strains.
Topics: Anti-Bacterial Agents; Cefotiam; Cross Infection; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans | 1990 |